Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Treasury Shares (2020 - 2025)

AC Immune (ACIU) has disclosed Treasury Shares for 5 consecutive years, with $248851.8 as the latest value for Q4 2024.

  • On a quarterly basis, Treasury Shares rose 110.23% to $248851.8 in Q4 2024 year-over-year; TTM through Dec 2024 was $248851.8, a 110.23% increase, with the full-year FY2024 number at $248851.8, up 112.85% from a year prior.
  • Treasury Shares was $248851.8 for Q4 2024 at AC Immune, up from $118372.2 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $248851.8 in Q4 2024 to a low of $110615.6 in Q4 2020.
  • A 5-year average of $148206.5 and a median of $128714.7 in 2022 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: fell 8.04% in 2023, then skyrocketed 110.23% in 2024.
  • AC Immune's Treasury Shares stood at $110615.6 in 2020, then grew by 21.57% to $134478.3 in 2021, then decreased by 4.29% to $128714.7 in 2022, then dropped by 8.04% to $118372.2 in 2023, then surged by 110.23% to $248851.8 in 2024.
  • Per Business Quant, the three most recent readings for ACIU's Treasury Shares are $248851.8 (Q4 2024), $118372.2 (Q4 2023), and $128714.7 (Q4 2022).